A citation-based method for searching scientific literature

Vladimir N Anisimov, Lev M Berstein, Peter A Egormin, Tatiana S Piskunova, Irina G Popovich, Mark A Zabezhinski, Irina G Kovalenko, Tatiana E Poroshina, Anna V Semenchenko, Mauro Provinciali, Francesca Re, Claudio Franceschi. Exp Gerontol 2005
Times Cited: 296







List of co-cited articles
1158 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Metformin and reduced risk of cancer in diabetic patients.
Josie M M Evans, Louise A Donnelly, Alistair M Emslie-Smith, Dario R Alessi, Andrew D Morris. BMJ 2005
33

Metformin improves healthspan and lifespan in mice.
Alejandro Martin-Montalvo, Evi M Mercken, Sarah J Mitchell, Hector H Palacios, Patricia L Mote, Morten Scheibye-Knudsen, Ana P Gomes, Theresa M Ward, Robin K Minor, Marie-José Blouin,[...]. Nat Commun 2013
690
28

Role of AMP-activated protein kinase in mechanism of metformin action.
G Zhou, R Myers, Y Li, Y Chen, X Shen, J Fenyk-Melody, M Wu, J Ventre, T Doebber, N Fujii,[...]. J Clin Invest 2001
28

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
I Ben Sahra, K Laurent, A Loubat, S Giorgetti-Peraldi, P Colosetti, P Auberger, J F Tanti, Y Le Marchand-Brustel, F Bost. Oncogene 2008
640
22

Metformin slows down aging and extends life span of female SHR mice.
Vladimir N Anisimov, Lev M Berstein, Peter A Egormin, Tatiana S Piskunova, Irina G Popovich, Mark A Zabezhinski, Margarita L Tyndyk, Maria V Yurova, Irina G Kovalenko, Tatiana E Poroshina,[...]. Cell Cycle 2008
217
21

Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo.
Vladimir N Anisimov, Peter A Egormin, Tatiana S Piskunova, Irina G Popovich, Margarita L Tyndyk, Maria N Yurova, Mark A Zabezhinski, Ivan V Anikin, Arseniy S Karkach, Alexey A Romanyukha. Cell Cycle 2010
132
21

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.
Gillian Libby, Louise A Donnelly, Peter T Donnan, Dario R Alessi, Andrew D Morris, Josie M M Evans. Diabetes Care 2009
741
19

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.
Mahvash Zakikhani, Ryan Dowling, I George Fantus, Nahum Sonenberg, Michael Pollak. Cancer Res 2006
806
19

If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice.
Vladimir N Anisimov, Lev M Berstein, Irina G Popovich, Mark A Zabezhinski, Peter A Egormin, Tatiana S Piskunova, Anna V Semenchenko, Margarita L Tyndyk, Maria N Yurova, Irina G Kovalenko,[...]. Aging (Albany NY) 2011
174
17

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.
Heather A Hirsch, Dimitrios Iliopoulos, Philip N Tsichlis, Kevin Struhl. Cancer Res 2009
802
17

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
Andrea Decensi, Matteo Puntoni, Pamela Goodwin, Massimiliano Cazzaniga, Alessandra Gennari, Bernardo Bonanni, Sara Gandini. Cancer Prev Res (Phila) 2010
608
17

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.
Anila K Madiraju, Derek M Erion, Yasmeen Rahimi, Xian-Man Zhang, Demetrios T Braddock, Ronald A Albright, Brett J Prigaro, John L Wood, Sanjay Bhanot, Michael J MacDonald,[...]. Nature 2014
672
16

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Marc Foretz, Sophie Hébrard, Jocelyne Leclerc, Elham Zarrinpashneh, Maud Soty, Gilles Mithieux, Kei Sakamoto, Fabrizio Andreelli, Benoit Viollet. J Clin Invest 2010
810
15

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Reuben J Shaw, Katja A Lamia, Debbie Vasquez, Seung-Hoi Koo, Nabeel Bardeesy, Ronald A Depinho, Marc Montminy, Lewis C Cantley. Science 2005
15

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.
M Y El-Mir, V Nogueira, E Fontaine, N Avéret, M Rigoulet, X Leverve. J Biol Chem 2000
933
15

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
Ryan J O Dowling, Mahvash Zakikhani, I George Fantus, Michael Pollak, Nahum Sonenberg. Cancer Res 2007
691
15

Metformin supplementation and life span in Fischer-344 rats.
Daniel L Smith, Calvin F Elam, Julie A Mattison, Mark A Lane, George S Roth, Donald K Ingram, David B Allison. J Gerontol A Biol Sci Med Sci 2010
93
15

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.
David E Harrison, Randy Strong, Zelton Dave Sharp, James F Nelson, Clinton M Astle, Kevin Flurkey, Nancy L Nadon, J Erby Wilkinson, Krystyna Frenkel, Christy S Carter,[...]. Nature 2009
14

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.
Adem Kalender, Anand Selvaraj, So Young Kim, Pawan Gulati, Sophie Brûlé, Benoit Viollet, Bruce E Kemp, Nabeel Bardeesy, Patrick Dennis, John J Schlager,[...]. Cell Metab 2010
574
14

Cellular and molecular mechanisms of metformin: an overview.
Benoit Viollet, Bruno Guigas, Nieves Sanz Garcia, Jocelyne Leclerc, Marc Foretz, Fabrizio Andreelli. Clin Sci (Lond) 2012
964
14

Metformin as a Tool to Target Aging.
Nir Barzilai, Jill P Crandall, Stephen B Kritchevsky, Mark A Espeland. Cell Metab 2016
426
14

Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice.
Vladimir N Anisimov, Tatiana S Piskunova, Irina G Popovich, Mark A Zabezhinski, Margarita L Tyndyk, Peter A Egormin, Maria V Yurova, Svetlana V Rosenfeld, Anna V Semenchenko, Irina G Kovalenko,[...]. Aging (Albany NY) 2010
89
14

Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice.
Richard A Miller, David E Harrison, C M Astle, Joseph A Baur, Angela Rodriguez Boyd, Rafael de Cabo, Elizabeth Fernandez, Kevin Flurkey, Martin A Javors, James F Nelson,[...]. J Gerontol A Biol Sci Med Sci 2011
581
13


Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism.
Filipe Cabreiro, Catherine Au, Kit-Yi Leung, Nuria Vergara-Irigaray, Helena M Cochemé, Tahereh Noori, David Weinkove, Eugene Schuster, Nicholas D E Greene, David Gems. Cell 2013
505
13



Long-term metformin use is associated with decreased risk of breast cancer.
Michael Bodmer, Christian Meier, Stephan Krähenbühl, Susan S Jick, Christoph R Meier. Diabetes Care 2010
342
12


Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.
Hiroshi Noto, Atsushi Goto, Tetsuro Tsujimoto, Mitsuhiko Noda. PLoS One 2012
374
12

Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.
Xu Huang, Stephan Wullschleger, Natalia Shpiro, Victoria A McGuire, Kei Sakamoto, Yvonne L Woods, Wendy McBurnie, Stewart Fleming, Dario R Alessi. Biochem J 2008
292
12

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.
Sao Jiralerspong, Shana L Palla, Sharon H Giordano, Funda Meric-Bernstam, Cornelia Liedtke, Chad M Barnett, Limin Hsu, Mien-Chie Hung, Gabriel N Hortobagyi, Ana M Gonzalez-Angulo. J Clin Oncol 2009
632
12

Rapamycin extends maximal lifespan in cancer-prone mice.
Vladimir N Anisimov, Mark A Zabezhinski, Irina G Popovich, Tatiana S Piskunova, Anna V Semenchenko, Margarita L Tyndyk, Maria N Yurova, Marina P Antoch, Mikhail V Blagosklonny. Am J Pathol 2010
185
11

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.
Monica Buzzai, Russell G Jones, Ravi K Amaravadi, Julian J Lum, Ralph J DeBerardinis, Fangping Zhao, Benoit Viollet, Craig B Thompson. Cancer Res 2007
720
11

Understanding the benefit of metformin use in cancer treatment.
Ryan J O Dowling, Pamela J Goodwin, Vuk Stambolic. BMC Med 2011
253
11


Metformin--mode of action and clinical implications for diabetes and cancer.
Ida Pernicova, Márta Korbonits. Nat Rev Endocrinol 2014
615
11

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro.
Irina N Alimova, Bolin Liu, Zeying Fan, Susan M Edgerton, Thomas Dillon, Stuart E Lind, Ann D Thor. Cell Cycle 2009
373
11

Metformin induces unique biological and molecular responses in triple negative breast cancer cells.
Bolin Liu, Zeying Fan, Susan M Edgerton, Xin-Sheng Deng, Irina N Alimova, Stuart E Lind, Ann D Thor. Cell Cycle 2009
300
11

Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth.
Carolyn Algire, Mahvash Zakikhani, Marie-Jose Blouin, Jian Hua Shuai, Michael Pollak. Endocr Relat Cancer 2008
150
11

Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria.
Hannah R Bridges, Andrew J Y Jones, Michael N Pollak, Judy Hirst. Biochem J 2014
364
11

Long-term metformin usage and cognitive function among older adults with diabetes.
Tze Pin Ng, Liang Feng, Keng Bee Yap, Tih Shih Lee, Chay Hoon Tan, Bengt Winblad. J Alzheimers Dis 2014
167
11

Prevention of pancreatic cancer induction in hamsters by metformin.
M B Schneider, H Matsuzaki, J Haorah, A Ulrich, J Standop, X Z Ding, T E Adrian, P M Pour. Gastroenterology 2001
231
10

Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
Issam Ben Sahra, Yannick Le Marchand-Brustel, Jean-François Tanti, Frédéric Bost. Mol Cancer Ther 2010
349
10

Metformin.
C J Bailey, R C Turner. N Engl J Med 1996
10

Rapamycin extends murine lifespan but has limited effects on aging.
Frauke Neff, Diana Flores-Dominguez, Devon P Ryan, Marion Horsch, Susanne Schröder, Thure Adler, Luciana Caminha Afonso, Juan Antonio Aguilar-Pimentel, Lore Becker, Lillian Garrett,[...]. J Clin Invest 2013
232
10

Metformin prevents tobacco carcinogen--induced lung tumorigenesis.
Regan M Memmott, Jose R Mercado, Colleen R Maier, Shigeru Kawabata, Stephen D Fox, Phillip A Dennis. Cancer Prev Res (Phila) 2010
302
10

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review.
Monica Franciosi, Giuseppe Lucisano, Emanuela Lapice, Giovanni F M Strippoli, Fabio Pellegrini, Antonio Nicolucci. PLoS One 2013
280
10

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.
Bernardo Bonanni, Matteo Puntoni, Massimiliano Cazzaniga, Giancarlo Pruneri, Davide Serrano, Aliana Guerrieri-Gonzaga, Alessandra Gennari, Maria Stella Trabacca, Viviana Galimberti, Paolo Veronesi,[...]. J Clin Oncol 2012
171
10

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.
Saroj Niraula, Ryan J O Dowling, Marguerite Ennis, Martin C Chang, Susan J Done, Nicky Hood, Jaime Escallon, Wey Liang Leong, David R McCready, Michael Reedijk,[...]. Breast Cancer Res Treat 2012
172
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.